Your session is about to expire
← Back to Search
HIIT for Reducing Frailty in Older Veterans (HIIT@Home Trial)
HIIT@Home Trial Summary
This trial is studying how high intensity exercise can help older people stay physically active and healthy as they age.
HIIT@Home Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.HIIT@Home Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am not considered frail according to a frailty score.I have severe COPD, CKD stage 3, or very high blood pressure.I am 60 years old or older.My gender or race does not limit my participation.
- Group 1: Center based attention control
- Group 2: Center based HIIT
- Group 3: Home based HIIT
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does my medical history make me a suitable candidate for this trial?
"This research is targeting 200 elderly individuals aged between 60 to 85 and who are classified as either non-frail or pre-frail (with a frailty score lower than 3). Other recruitment requirements include being of any gender, race, and having medical clearance for exercise."
Are there any opportunities for participation in this experiment?
"According to clinicaltrials.gov, this particular medical trial is not currently enrolling participants; the initial post was published on February 1st 2023 and it had its last update on November 14th 2022. However, there are 146 other studies that need patients right now."
What goals are scientists hoping to accomplish with this experiment?
"The primary endpoint of this trial, measured over a 12-week period from baseline, will be levels of Interleukin 6. Secondary outcomes involve observation of the Amyloid beta 42/40 ratio, Brain Derived Neurotrophic Factor (BDNF), and Cognitive screen - SLUMS; these are assessed respectively through serum cognitive markers, picograms per milliliter readings for BDNF changes from pre- to posttreatment phases, and the VA – St Louis University Mental Survey which involves memory testing & shape recognition alongside Cognivue's visual reaction time test."
Does this clinical research extend to geriatric individuals?
"This medical research is seeking out individuals aged between sixty and eighty-five for enrollment."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger